在持久性心房动中,左心房压和显著的三腹吐是持续性心房动
Yuewu Lin1, Maolin Ye1, Yan Qiu1
1Zhangzhou Affiliated Hospital of Fujian Medical University, Department of Geriatrics, Zhangzhou, Fujian, China.
Frontiers in cardiovascular medicine
|June 23, 2025
概括
升高的左心房压 (LAP) 与心房动 (AF) 患者中中度至严重的三腹吐 (TR) 有关. 早期识别高LAP和右心脏重塑可以指导预防TR进展的干预措施.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 医疗成像医学成像
背景情况:
- 心房动 (AF) 是已知的三回 (TR) 的一个已知贡献者.
- 升高的左心房压 (LAP) 是TR进展的关键因素,并影响患者的治疗结果.
研究的目的:
- 在心房 (AF) 患者中研究左心房压升高 (LAP) 和三回 (TR) 之间的关系.
主要方法:
- 分析了一组189名AF患者的队列,这些患者正在接受左心房尾关闭.
- 患者被分为中度至重度TR和无显著TR组.
- 基线特征,成像发现和随访数据在各组之间进行了比较.
主要成果:
- 中度至重度的TR组年龄较大,有较长的持续性AF病史,并表现出较低的血红蛋白和血红素水平.
- 患有中度至重度TR的患者左心房压力 (LAP) 更高,包括左心房静脉压力 (LASP),以及 mitrale regurgitation 和肺高血压的患病率更高.
- 升高的LAP与持续性AF患者的右心脏重塑和显著的TR密切相关. 确定了LASP,额头吐和AF持续时间作为显著TR的独立预测因素.
结论:
- 早期识别升高的LAP和右心脏重塑对于指导预防TR进展的干预至关重要.
- LASP和AF持续时间是TR的显著预测指标,突出显示在治疗规划中需要全面的临床评估.
相关概念视频
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
59
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
59
01:15Aortic Regurgitation I: Introduction
46
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
46
01:20Mitral Regurgitation I: Introduction
64
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
64
01:25Aortic Regurgitation III: Medical Management
53
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
53
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
60
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
60
01:25Mitral Regurgitation III: Medical Management
35
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
35